Literature DB >> 8289151

The clinical implications of autoantibody detection in rheumatology.

P J Charles1, R N Maini.   

Abstract

The laboratory plays an increasing role in the diagnosis and clinical management of patients with rheumatic diseases. It is therefore essential that the results of laboratory tests are both accurate and reliable, and give clinicians correct information. It is also important to keep clinicians informed of the changes occurring in the rapidly evolving field of investigation of autoantibodies.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8289151      PMCID： PMC5396709     

Source DB:  PubMed          Journal:  J R Coll Physicians Lond        ISSN： 0035-8819


  42 in total

Review 1.  Fundamental and clinical aspects of anti neutrophil cytoplasmic antibodies (ANCA).

Authors:  E C Hagen; B E Ballieux; M R Daha; L A van Es; F J Van der Woude
Journal:  Autoimmunity       Date:  1992       Impact factor: 2.815

Review 2.  Antibodies to antinuclear subsets in systemic lupus erythematosus and rheumatoid arthritis.

Authors:  J S Smolen; W Hassfeld; W Graninger; G Steiner
Journal:  Clin Exp Rheumatol       Date:  1990 Jul-Aug       Impact factor: 4.473

3.  Use of recombinant RNP peptides 70K and A in an ELISA for measurement of antibodies in mixed connective tissue disease: a longitudinal follow up of 18 patients.

Authors:  D J de Rooij; W J Habets; L B van de Putte; M H Hoet; A L Verbeek; W J van Venrooij
Journal:  Ann Rheum Dis       Date:  1990-06       Impact factor: 19.103

4.  Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease.

Authors:  E Matsuura; Y Igarashi; M Fujimoto; K Ichikawa; T Koike
Journal:  Lancet       Date:  1990-07-21       Impact factor: 79.321

5.  Antibodies to protein P in systemic lupus erythematosus.

Authors:  L S Teh; A E Bedwell; D A Isenberg; C Gordon; P Emery; P J Charles; M Harper; N Amos; B D Williams
Journal:  Ann Rheum Dis       Date:  1992-04       Impact factor: 19.103

Review 6.  Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance.

Authors:  P E Love; S A Santoro
Journal:  Ann Intern Med       Date:  1990-05-01       Impact factor: 25.391

7.  Disease activity and joint damage progression in early rheumatoid arthritis: relation to IgG, IgA, and IgM rheumatoid factor.

Authors:  K B Eberhardt; L Truedsson; H Pettersson; B Svensson; L Stigsson; J L Eberhardt; F A Wollheim
Journal:  Ann Rheum Dis       Date:  1990-11       Impact factor: 19.103

Review 8.  Anti-Ro(SSA) and anti-La(SSB) antibodies in lupus erythematosus and Sjögren's syndrome.

Authors:  T T Provost
Journal:  Keio J Med       Date:  1991-06

9.  Anti-neutrophil cytoplasm antibodies in rheumatoid arthritis.

Authors:  J A Savige; M C Gallicchio; A Stockman; T J Cunningham; M J Rowley; T Georgiou; D Davies
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

Review 10.  The Consensus Workshops for the Detection of Autoantibodies to Intracellular Antigens in Rheumatic Diseases: 1989-1992.

Authors:  P J Charles; W J van Venrooij; R N Maini
Journal:  Clin Exp Rheumatol       Date:  1992 Sep-Oct       Impact factor: 4.473
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.